Grad 3 - eller 4- trombocytopeni og neutropeni forekom hos henholdsvis 19% og 17% af patienterne behandlet for malignt gliom.
Grade 3 or 4 thrombocytopenia and neutropenia occurred in 19% and 17% respectively, of patients treated for malignant glioma.